Company intelligence / Profile preview

Steth IO

Ownership: Private
Development stage: Other

Overview

Steth IO appears to be a healthcare technology company focused on digital stethoscope and connected auscultation solutions rather than a therapeutics developer. Based on the name and likely market context, the company seems oriented toward device-enabled remote or point-of-care cardiopulmonary assessment. It does not appear to have a traditional drug pipeline, therapeutic targets, or clinical-stage biopharmaceutical programs. The business is more consistent with digital health, medical device, and software-enabled diagnostics infrastructure for healthcare providers.

Modalities: DeviceSoftware
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Steth IO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Steth IO.

Explore the full profile